Zymeworks Inc (ZYME) Directors and Executive Officers

Officers & Directors

Kelvin Neu
Director

Susan Mahony
Director

Kenneth Galbraith
Chair of the Board of Directors, President and Chief Executive Officer (Principal Executive Officer)

Derek Miller
Director

Scott Platshon
Director

Troy M. Cox
Director

Hollings C. Renton
Director

Nancy Davidson
Director

Carlos Campoy
Director

Alessandra Cesano
Director

Christopher Astle
Senior Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Chartered Professional Accountants
; Vancouver, Canada ,

Zymeworks Inc currently has 264 employees.

News about Zymeworks Inc Key Personnel

Zymeworks Charts Course Amid Financial Challenges and Promising Pipeline Developments

Vancouver, British Columbia—In a press release dated January 8, 2025, Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology firm, articulated its strategic priorities and outlook for the years 2025 and 2026. The company aims to enhance standards of care for complex conditions including cancer, inflammation, and autoimmune diseases through its innovative portfolio of multifunctional biotherapeutics. This forward-looking statement comes amid recent fluctuations in the company’s stock performance and employee productivity metrics.Over the past month, Zymeworks saw its stock price rise by an encouraging 5.7%. This uptick can be viewed as a sign of investor optimism regarding the company’s future in...